Biotricity CEO Speaks to the Future of AI and its Contributions to Healthcare

Company's proprietary AI technology allows for expansion into predictive monitoring and new disease profiling

The New England Journal of Medicine article cites AI and its potential for increased healthcare efficiency and insights

REDWOOD CITY, CA / ACCESSWIRE / May 23, 2023 / Dr. Waqaas Al-Siddiq, Founder and CEO of Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnostic and consumer healthcare technology company, today commented on contributions of artificial intelligence (AI) and machine learning and its transformative nature for healthcare.

As stated in The New England Journal of Medicine, March 30, 2023 article entitled, Artificial Intelligence in Medicine, "Tools that utilize AI have come into increasing use in analyzing and interpreting large research databases containing information ranging from laboratory findings to clinical data. All these tools offer the potential for increased efficiency and may, perhaps, render insights that are difficult to attain with more traditional data-analysis methods."

Biotricity sees AI algorithms are now developing the ability to identify earlier signs of illness, help with precision medicine therapies, and streamline administrative tasks - thereby enabling healthcare practitioners to deliver more efficient and effective care one-on-one.

With a focus on improving patient outcomes through innovative solutions, Biotricity has been working with AI technology and its large datasets over the past few years to develop the next generation of diagnostics. The company is well-positioned to make a significant contribution to the advancement of healthcare by using AI-- placing it at the forefront of the healthcare industry's AI revolution.

The Company's flagship product, Bioflux, is an advanced remote cardiac monitoring system with built-in algorithms that leverages AI to deliver more accurate and earlier diagnoses leading to enhanced patient care. The Bioflux system is a turn-key solution designed to provide physicians with 24/7 real-time access to patient data, enabling them to monitor patient health more closely and make informed decisions sooner. Its proprietary solutions have recorded data on over 112 billion heartbeats for deep data analysis.